<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1997-11-01" modified="2017-12-20" version="164">
<accession>Q92781</accession>
<accession>O00179</accession>
<accession>Q8TAI2</accession>
<name>RDH1_HUMAN</name>
<protein>
<recommendedName>
<fullName>11-cis retinol dehydrogenase</fullName>
<shortName>11-cis RDH</shortName>
<shortName>11-cis RoDH</shortName>
<ecNumber>1.1.1.315</ecNumber>
</recommendedName>
<alternativeName>
<fullName>9-cis retinol dehydrogenase</fullName>
<shortName>9cRDH</shortName>
</alternativeName>
<alternativeName>
<fullName>Retinol dehydrogenase 5</fullName>
</alternativeName>
<alternativeName>
<fullName>Short chain dehydrogenase/reductase family 9C member 5</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">RDH5</name>
<name type="synonym">HSD17B9</name>
<name type="synonym">RDH1</name>
<name type="synonym">SDR9C5</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1996" name="Genomics" volume="36" first="424" last="430">
<title>Primary structure of human 11-cis retinol dehydrogenase and organization and chromosomal localization of the corresponding gene.</title>
<authorList>
<person name="Simon A."/>
<person name="Lagercrantz J."/>
<person name="Bajalica-Lagercrantz S."/>
<person name="Eriksson U."/>
</authorList>
<dbReference type="PubMed" id="8884265"/>
<dbReference type="DOI" id="10.1006/geno.1996.0487"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1997" name="J. Biol. Chem." volume="272" first="11744" last="11749">
<title>Identification and characterization of a stereospecific human enzyme that catalyzes 9-cis-retinol oxidation. A possible role in 9-cis-retinoic acid formation.</title>
<authorList>
<person name="Mertz J.R."/>
<person name="Shang E."/>
<person name="Piantedosi R."/>
<person name="Wei S."/>
<person name="Wolgemuth D.J."/>
<person name="Blaner W.S."/>
</authorList>
<dbReference type="PubMed" id="9115228"/>
<dbReference type="DOI" id="10.1074/jbc.272.18.11744"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>PATHWAY</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>VARIANT GLY-70</scope>
<source>
<tissue>Mammary gland</tissue>
</source>
</reference>
<reference key="3">
<citation type="submission" date="1997-12" db="EMBL/GenBank/DDBJ databases">
<title>Retinol dehydrogenase: complete genomic sequence and its relationship to retinitis pigmentosa.</title>
<authorList>
<person name="Gu S."/>
<person name="Jablonka S."/>
<person name="Gal A."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<source>
<tissue>Blood</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="1999" name="J. Lipid Res." volume="40" first="2279" last="2292">
<title>Biochemical properties, tissue expression, and gene structure of a short chain dehydrogenase/reductase able to catalyze cis-retinol oxidation.</title>
<authorList>
<person name="Gamble M.V."/>
<person name="Shang E."/>
<person name="Zott R.P."/>
<person name="Mertz J.R."/>
<person name="Wolgemuth D.J."/>
<person name="Blaner W.S."/>
</authorList>
<dbReference type="PubMed" id="10588954"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="49251" last="49257">
<title>Biochemical defects in 11-cis-retinol dehydrogenase mutants associated with fundus albipunctatus.</title>
<authorList>
<person name="Liden M."/>
<person name="Romert A."/>
<person name="Tryggvason K."/>
<person name="Persson B."/>
<person name="Eriksson U."/>
</authorList>
<dbReference type="PubMed" id="11675386"/>
<dbReference type="DOI" id="10.1074/jbc.M107337200"/>
</citation>
<scope>SUBUNIT</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>CHARACTERIZATION OF VARIANTS FALBI SER-35; PHE-73; ILE-105; ASN-128; TRP-157; TRP-238; GLY-264; HIS-280; PRO-294 AND LEU-310 DELINS GLU-VAL</scope>
</reference>
<reference key="7">
<citation type="journal article" date="1999" name="Mol. Vis." volume="5" first="41" last="41">
<title>11-cis retinol dehydrogenase mutations as a major cause of the congenital night-blindness disorder known as fundus albipunctatus.</title>
<authorList>
<person name="Gonzalez-Fernandez F."/>
<person name="Kurz D."/>
<person name="Bao Y."/>
<person name="Newman S."/>
<person name="Conway B.P."/>
<person name="Young J.E."/>
<person name="Han D.P."/>
<person name="Khani S.C."/>
</authorList>
<dbReference type="PubMed" id="10617778"/>
</citation>
<scope>VARIANTS FALBI TRP-238; HIS-280 AND PRO-294</scope>
</reference>
<reference key="8">
<citation type="journal article" date="1999" name="Nat. Genet." volume="22" first="188" last="191">
<title>Mutations in the gene encoding 11-cis retinol dehydrogenase cause delayed dark adaptation and fundus albipunctatus.</title>
<authorList>
<person name="Yamamoto H."/>
<person name="Simon A."/>
<person name="Eriksson U."/>
<person name="Harris E."/>
<person name="Berson E.L."/>
<person name="Dryja T.P."/>
</authorList>
<dbReference type="PubMed" id="10369264"/>
<dbReference type="DOI" id="10.1038/9707"/>
</citation>
<scope>VARIANTS FALBI PHE-73 AND TRP-238</scope>
<scope>VARIANT VAL-33</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2000" name="Am. J. Ophthalmol." volume="130" first="672" last="675">
<title>A novel compound heterozygous mutation in the RDH5 gene in a patient with fundus albipunctatus.</title>
<authorList>
<person name="Kuroiwa S."/>
<person name="Kikuchi T."/>
<person name="Yoshimura N."/>
</authorList>
<dbReference type="PubMed" id="11078852"/>
<dbReference type="DOI" id="10.1016/S0002-9394(00)00765-0"/>
</citation>
<scope>VARIANTS FALBI GLY-177 AND HIS-280</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2000" name="Invest. Ophthalmol. Vis. Sci." volume="41" first="3925" last="3932">
<title>A high association with cone dystrophy in Fundus albipunctatus caused by mutations of the RDH5 gene.</title>
<authorList>
<person name="Nakamura M."/>
<person name="Hotta Y."/>
<person name="Tanikawa A."/>
<person name="Terasaki H."/>
<person name="Miyake Y."/>
</authorList>
<dbReference type="PubMed" id="11053295"/>
</citation>
<scope>VARIANTS FALBI SER-35; ARG-107; MET-132; HIS-280; HIS-281 AND 309-GLU-VAL-310 DELINS</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2000" name="Invest. Ophthalmol. Vis. Sci." volume="41" first="3933" last="3935">
<title>Mutations in the 11-cis retinol dehydrogenase gene in Japanese patients with Fundus albipunctatus.</title>
<authorList>
<person name="Hirose E."/>
<person name="Inoue Y."/>
<person name="Morimura H."/>
<person name="Okamoto N."/>
<person name="Fukuda M."/>
<person name="Yamamoto S."/>
<person name="Fujikado T."/>
<person name="Tano Y."/>
</authorList>
<dbReference type="PubMed" id="11053296"/>
</citation>
<scope>VARIANTS FALBI GLY-264 AND LEU-310 DELINS GLU-VAL</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2001" name="Ophthalmology" volume="108" first="1479" last="1484">
<title>Null mutation in the human 11-cis retinol dehydrogenase gene associated with fundus albipunctatus.</title>
<authorList>
<person name="Driessen C.A."/>
<person name="Janssen B.P."/>
<person name="Winkens H.J."/>
<person name="Kuhlmann L.D."/>
<person name="Van Vugt A.H."/>
<person name="Pinckers A.J."/>
<person name="Deutman A.F."/>
<person name="Janssen J.J."/>
</authorList>
<dbReference type="PubMed" id="11470705"/>
<dbReference type="DOI" id="10.1016/S0161-6420(01)00640-6"/>
</citation>
<scope>VARIANT FALBI TRP-267</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2003" name="Am. J. Ophthalmol." volume="135" first="917" last="919">
<title>Macular dystrophy in a Japanese family with fundus albipunctatus.</title>
<authorList>
<person name="Hotta K."/>
<person name="Nakamura M."/>
<person name="Kondo M."/>
<person name="Ito S."/>
<person name="Terasaki H."/>
<person name="Miyake Y."/>
<person name="Hida T."/>
</authorList>
<dbReference type="PubMed" id="12788147"/>
<dbReference type="DOI" id="10.1016/S0002-9394(02)02290-0"/>
</citation>
<scope>VARIANT FALBI ARG-107</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2003" name="Am. J. Ophthalmol." volume="136" first="572" last="574">
<title>A novel RDH5 gene mutation in a patient with fundus albipunctatus presenting with macular atrophy and fading white dots.</title>
<authorList>
<person name="Yamamoto H."/>
<person name="Yakushijin K."/>
<person name="Kusuhara S."/>
<person name="Escano M.F."/>
<person name="Nagai A."/>
<person name="Negi A."/>
</authorList>
<dbReference type="PubMed" id="12967826"/>
<dbReference type="DOI" id="10.1016/S0002-9394(03)00332-5"/>
</citation>
<scope>VARIANT FALBI PHE-164</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2015" name="J. Appl. Genet." volume="56" first="317" last="327">
<title>Fundus albipunctatus: review of the literature and report of a novel RDH5 gene mutation affecting the invariant tyrosine (p.Tyr175Phe).</title>
<authorList>
<person name="Skorczyk-Werner A."/>
<person name="Pawlowski P."/>
<person name="Michalczuk M."/>
<person name="Warowicka A."/>
<person name="Wawrocka A."/>
<person name="Wicher K."/>
<person name="Bakunowicz-Lazarczyk A."/>
<person name="Krawczynski M.R."/>
</authorList>
<dbReference type="PubMed" id="25820994"/>
<dbReference type="DOI" id="10.1007/s13353-015-0281-x"/>
</citation>
<scope>VARIANT FALBI PHE-175</scope>
</reference>
<comment type="function">
<text evidence="4 14">Stereospecific 11-cis retinol dehydrogenase, which catalyzes the final step in the biosynthesis of 11-cis retinaldehyde, the universal chromophore of visual pigments. Also able to oxidize 9-cis-retinol and 13-cis-retinol, but not all-trans-retinol. Active in the presence of NAD as cofactor but not in the presence of NADP.</text>
</comment>
<comment type="catalytic activity">
<text evidence="4 14">11-cis-retinol-[retinal-binding-protein] + NAD(+) = 11-cis-retinal-[retinol-binding-protein] + NADH.</text>
</comment>
<comment type="enzyme regulation">
<text evidence="4">Inhibited by 9-cis-, 13-cis- and all-trans-retinoic acids, with the most potent inhibitor being 13-cis-retinoic acid. Weakly inhibited by oleic acid.</text>
</comment>
<comment type="biophysicochemical properties">
<phDependence>
<text evidence="14">Optimum pH is 7.5-8.0 for 9-cis retinol dehydrogenase activity.</text>
</phDependence>
</comment>
<comment type="pathway" evidence="14">
<text>Cofactor metabolism; retinol metabolism.</text>
</comment>
<comment type="subunit">
<text evidence="10">Homodimer.</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="10">Membrane</location>
<topology evidence="10">Peripheral membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="10">Endoplasmic reticulum lumen</location>
</subcellularLocation>
</comment>
<comment type="tissue specificity">
<text evidence="14">Abundant in the retinal pigment epithelium. Expressed at high levels in mammary tissue, kidney and testis, and at lower levels in liver, heart, adrenal gland, lung, pancreas and skeletal muscle.</text>
</comment>
<comment type="disease" evidence="3 5 6 7 8 9 10 11 12 13">
<disease id="DI-04584">
<name>Fundus albipunctatus</name>
<acronym>FALBI</acronym>
<description>A form of fleck retina disease characterized by discrete uniform white dots over the entire fundus with greatest density in the mid-periphery and no macular involvement. Night blindness occurs. Inheritance can be autosomal dominant or autosomal recessive.</description>
<dbReference type="MIM" id="136880"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="15">Belongs to the short-chain dehydrogenases/reductases (SDR) family.</text>
</comment>
<comment type="online information" name="Mutations of the RDH5 gene">
<link uri="http://www.retina-international.org/files/sci-news/rdh5mut.htm"/>
<text>Retina International's Scientific Newsletter</text>
</comment>
<dbReference type="EC" id="1.1.1.315"/>
<dbReference type="EMBL" id="U43559">
<property type="protein sequence ID" value="AAC50725.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U89717">
<property type="protein sequence ID" value="AAB93668.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF037062">
<property type="protein sequence ID" value="AAC09250.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC028298">
<property type="protein sequence ID" value="AAH28298.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS31829.1"/>
<dbReference type="RefSeq" id="NP_001186700.1">
<property type="nucleotide sequence ID" value="NM_001199771.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_002896.2">
<property type="nucleotide sequence ID" value="NM_002905.3"/>
</dbReference>
<dbReference type="UniGene" id="Hs.600940"/>
<dbReference type="ProteinModelPortal" id="Q92781"/>
<dbReference type="SMR" id="Q92781"/>
<dbReference type="BioGrid" id="111892">
<property type="interactions" value="8"/>
</dbReference>
<dbReference type="IntAct" id="Q92781">
<property type="interactions" value="1"/>
</dbReference>
<dbReference type="STRING" id="9606.ENSP00000257895"/>
<dbReference type="DrugBank" id="DB00157">
<property type="generic name" value="NADH"/>
</dbReference>
<dbReference type="DrugBank" id="DB00162">
<property type="generic name" value="Vitamin A"/>
</dbReference>
<dbReference type="SwissLipids" id="SLP:000000797"/>
<dbReference type="iPTMnet" id="Q92781"/>
<dbReference type="PhosphoSitePlus" id="Q92781"/>
<dbReference type="BioMuta" id="RDH5"/>
<dbReference type="DMDM" id="2492753"/>
<dbReference type="PaxDb" id="Q92781"/>
<dbReference type="PeptideAtlas" id="Q92781"/>
<dbReference type="PRIDE" id="Q92781"/>
<dbReference type="DNASU" id="5959"/>
<dbReference type="Ensembl" id="ENST00000257895">
<property type="protein sequence ID" value="ENSP00000257895"/>
<property type="gene ID" value="ENSG00000135437"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000548082">
<property type="protein sequence ID" value="ENSP00000447128"/>
<property type="gene ID" value="ENSG00000135437"/>
</dbReference>
<dbReference type="GeneID" id="5959"/>
<dbReference type="KEGG" id="hsa:5959"/>
<dbReference type="UCSC" id="uc001shk.4">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="5959"/>
<dbReference type="DisGeNET" id="5959"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000135437.9"/>
<dbReference type="GeneCards" id="RDH5"/>
<dbReference type="HGNC" id="HGNC:9940">
<property type="gene designation" value="RDH5"/>
</dbReference>
<dbReference type="HPA" id="HPA063345"/>
<dbReference type="MalaCards" id="RDH5"/>
<dbReference type="MIM" id="136880">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="601617">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q92781"/>
<dbReference type="OpenTargets" id="ENSG00000135437"/>
<dbReference type="Orphanet" id="227796">
<property type="disease" value="Fundus albipunctatus"/>
</dbReference>
<dbReference type="Orphanet" id="52427">
<property type="disease" value="Retinitis punctata albescens"/>
</dbReference>
<dbReference type="PharmGKB" id="PA34308"/>
<dbReference type="eggNOG" id="KOG1610">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410Y7FK">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00900000140775"/>
<dbReference type="HOVERGEN" id="HBG005482"/>
<dbReference type="InParanoid" id="Q92781"/>
<dbReference type="KO" id="K00061"/>
<dbReference type="OMA" id="IIGPTPW"/>
<dbReference type="OrthoDB" id="EOG091G0LMI"/>
<dbReference type="PhylomeDB" id="Q92781"/>
<dbReference type="TreeFam" id="TF325617"/>
<dbReference type="BioCyc" id="MetaCyc:HS06003-MONOMER"/>
<dbReference type="BRENDA" id="1.1.1.300">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="BRENDA" id="1.1.1.315">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2453864">
<property type="pathway name" value="Retinoid cycle disease events"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2453902">
<property type="pathway name" value="The canonical retinoid cycle in rods (twilight vision)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5365859">
<property type="pathway name" value="RA biosynthesis pathway"/>
</dbReference>
<dbReference type="UniPathway" id="UPA00912"/>
<dbReference type="ChiTaRS" id="RDH5">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="RDH5"/>
<dbReference type="GenomeRNAi" id="5959"/>
<dbReference type="PRO" id="PR:Q92781"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 12"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000135437"/>
<dbReference type="CleanEx" id="HS_RDH5"/>
<dbReference type="ExpressionAtlas" id="Q92781">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q92781">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0044297">
<property type="term" value="C:cell body"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005788">
<property type="term" value="C:endoplasmic reticulum lumen"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005789">
<property type="term" value="C:endoplasmic reticulum membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0004745">
<property type="term" value="F:retinol dehydrogenase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0050896">
<property type="term" value="P:response to stimulus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0001523">
<property type="term" value="P:retinoid metabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0042572">
<property type="term" value="P:retinol metabolic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-UniPathway"/>
</dbReference>
<dbReference type="GO" id="GO:0007601">
<property type="term" value="P:visual perception"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="InterPro" id="IPR036291">
<property type="entry name" value="NAD(P)-bd_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR002347">
<property type="entry name" value="SDR_fam"/>
</dbReference>
<dbReference type="Pfam" id="PF00106">
<property type="entry name" value="adh_short"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00081">
<property type="entry name" value="GDHRDH"/>
</dbReference>
<dbReference type="PRINTS" id="PR00080">
<property type="entry name" value="SDRFAMILY"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF51735">
<property type="entry name" value="SSF51735"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0256">Endoplasmic reticulum</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0520">NAD</keyword>
<keyword id="KW-0560">Oxidoreductase</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0716">Sensory transduction</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0844">Vision</keyword>
<feature type="signal peptide" evidence="2">
<location>
<begin position="1"/>
<end position="23"/>
</location>
</feature>
<feature type="chain" description="11-cis retinol dehydrogenase" id="PRO_0000054758">
<location>
<begin position="24"/>
<end position="318"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="NADP" evidence="1">
<location>
<begin position="32"/>
<end position="56"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="1">
<location>
<position position="175"/>
</location>
</feature>
<feature type="binding site" description="Substrate" evidence="1">
<location>
<position position="163"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="2">
<location>
<position position="160"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs3138143." id="VAR_052321">
<original>R</original>
<variation>Q</variation>
<location>
<position position="21"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs62638195." id="VAR_009272" evidence="3">
<original>I</original>
<variation>V</variation>
<location>
<position position="33"/>
</location>
</feature>
<feature type="sequence variant" description="In FALBI; decreased stability; dbSNP:rs759359491." id="VAR_016814" evidence="6 10">
<original>G</original>
<variation>S</variation>
<location>
<position position="35"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1058635." id="VAR_052322" evidence="14">
<original>R</original>
<variation>G</variation>
<location>
<position position="70"/>
</location>
</feature>
<feature type="sequence variant" description="In FALBI; decreased stability; loss of enzymatic activity; accumulates in the perinuclear region; dbSNP:rs62638185." id="VAR_009273" evidence="3 10">
<original>S</original>
<variation>F</variation>
<location>
<position position="73"/>
</location>
</feature>
<feature type="sequence variant" description="In FALBI; decreased stability; dbSNP:rs765993603." id="VAR_068716" evidence="10">
<original>L</original>
<variation>I</variation>
<location>
<position position="105"/>
</location>
</feature>
<feature type="sequence variant" description="In FALBI; associated with macular dystrophy." id="VAR_016815" evidence="6 11">
<original>G</original>
<variation>R</variation>
<location>
<position position="107"/>
</location>
</feature>
<feature type="sequence variant" description="In FALBI; decreased stability; dbSNP:rs377029071." id="VAR_068717" evidence="10">
<original>D</original>
<variation>N</variation>
<location>
<position position="128"/>
</location>
</feature>
<feature type="sequence variant" description="In FALBI; dbSNP:rs62638187." id="VAR_016816" evidence="6">
<original>V</original>
<variation>M</variation>
<location>
<position position="132"/>
</location>
</feature>
<feature type="sequence variant" description="In FALBI; decreased stability; dbSNP:rs104894374." id="VAR_068718" evidence="10">
<original>R</original>
<variation>W</variation>
<location>
<position position="157"/>
</location>
</feature>
<feature type="sequence variant" description="In FALBI." id="VAR_016817" evidence="12">
<original>V</original>
<variation>F</variation>
<location>
<position position="164"/>
</location>
</feature>
<feature type="sequence variant" description="In FALBI; dbSNP:rs758411232." id="VAR_075309" evidence="13">
<original>Y</original>
<variation>F</variation>
<location>
<position position="175"/>
</location>
</feature>
<feature type="sequence variant" description="In FALBI; dbSNP:rs104894373." id="VAR_016818" evidence="8">
<original>V</original>
<variation>G</variation>
<location>
<position position="177"/>
</location>
</feature>
<feature type="sequence variant" description="In FALBI; decreased stability; loss of enzymatic activity; accumulates in the perinuclear region; dbSNP:rs62638191." id="VAR_009274" evidence="3 5 10">
<original>G</original>
<variation>W</variation>
<location>
<position position="238"/>
</location>
</feature>
<feature type="sequence variant" description="In FALBI; decreased stability." id="VAR_068719" evidence="7 10">
<original>V</original>
<variation>G</variation>
<location>
<position position="264"/>
</location>
</feature>
<feature type="sequence variant" description="In FALBI." id="VAR_016819" evidence="9">
<original>C</original>
<variation>W</variation>
<location>
<position position="267"/>
</location>
</feature>
<feature type="sequence variant" description="In FALBI; decreased stability; loss of enzymatic activity; dbSNP:rs62638193." id="VAR_016820" evidence="5 6 8 10">
<original>R</original>
<variation>H</variation>
<location>
<position position="280"/>
</location>
</feature>
<feature type="sequence variant" description="In FALBI; dbSNP:rs62638194." id="VAR_016821" evidence="6">
<original>Y</original>
<variation>H</variation>
<location>
<position position="281"/>
</location>
</feature>
<feature type="sequence variant" description="In FALBI; no effect on enzymatic activity; accumulates in the perinuclear region; dbSNP:rs111033593." id="VAR_016822" evidence="5 10">
<original>A</original>
<variation>P</variation>
<location>
<position position="294"/>
</location>
</feature>
<feature type="sequence variant" description="In FALBI; loss of enzymatic activity; accumulates in the perinuclear region." id="VAR_016823" evidence="7 10">
<original>L</original>
<variation>EV</variation>
<location>
<position position="310"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; AAH28298." ref="4" evidence="15">
<original>F</original>
<variation>L</variation>
<location>
<position position="30"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAB93668." ref="2" evidence="15">
<original>RG</original>
<variation>KS</variation>
<location>
<begin position="51"/>
<end position="52"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAB93668." ref="2" evidence="15">
<original>RLH</original>
<variation>GFN</variation>
<location>
<begin position="75"/>
<end position="77"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAB93668." ref="2" evidence="15">
<original>V</original>
<variation>F</variation>
<location>
<position position="89"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAB93668." ref="2" evidence="15">
<original>V</original>
<variation>E</variation>
<location>
<position position="200"/>
</location>
</feature>
<evidence key="1" type="ECO:0000250"/>
<evidence key="2" type="ECO:0000255"/>
<evidence key="3" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10369264"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10588954"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10617778"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11053295"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11053296"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11078852"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11470705"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11675386"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12788147"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12967826"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25820994"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9115228"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000305"/>
<sequence length="318" mass="34979" checksum="2CE24343F2EEA4B7" modified="1997-02-01" version="1" precursor="true">
MWLPLLLGALLWAVLWLLRDRQSLPASNAFVFITGCDSGFGRLLALQLDQRGFRVLASCL
TPSGAEDLQRVASSRLHTTLLDITDPQSVQQAAKWVEMHVKEAGLFGLVNNAGVAGIIGP
TPWLTRDDFQRVLNVNTMGPIGVTLALLPLLQQARGRVINITSVLGRLAANGGGYCVSKF
GLEAFSDSLRRDVAHFGIRVSIVEPGFFRTPVTNLESLEKTLQACWARLPPATQAHYGGA
FLTKYLKMQQRIMNLICDPDLTKVSRCLEHALTARHPRTRYSPGWDAKLLWLPASYLPAS
LVDAVLTWVLPKPAQAVY
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>